ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
QuidelOrtho Corporation

QuidelOrtho Corporation (QDEL)

18,27
0,83
(4,76%)
Geschlossen 11 Juli 10:00PM
18,3355
0,0655
(0,36%)
Nach Börsenschluss: 1:56AM

QuidelOrtho Corporation (QDEL) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
18,3355
( 5,13% )
Gebot
18,20
Fragen
18,91
Volumen
1.278.543
Durchschnittliches Volumen (3 Mio.)
US$ 2.310.405
Finanzvolumen
US$ 22.954.801
17,17 Tagesbereich 18,565
9,92 52-Wochen-Bereich 35,575
Marktkapitalisierung
Unternehmenswert
3,911B
Handelsende
17,44
Handelsbeginn
17,50
Letzte Trade
1
@
18.555
Letzter Handelszeitpunkt
VWAP
17,9539
Erlöse (LTM)
2,66B
Nettogewinn (LTM)
-1,21B
Ausgegebene Aktien
68.190.989
Streubesitz (%)
91,08%
Institutioneller Besitz (%)
124,19%
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,97
Kurs-Umsatz-Verhältnis (KUV)
0,44
Gewinn pro Aktie (EPS)
-17,81
Beta
0,69

Über QuidelOrtho Corporation

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily... QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California. Mehr anzeigen

Sektor
Health Care
Branche
Health Care Equipment & Supplies
Hauptsitz
San Diego, United States
Gegründet
1979
QuidelOrtho Corporation is listed in the Health Care sector of the NASDAQ with ticker QDEL. The last closing price for QuidelOrtho was US$17,44. Over the last year, QuidelOrtho shares have traded in a share price range of US$ 9,92 to US$ 35,575.

QuidelOrtho currently has 68.190.989 shares in issue. The market capitalisation of QuidelOrtho is US$1,25 billion. QuidelOrtho has a price to earnings ratio (PE ratio) of -0.97.

QDEL Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.2445-1.3159311087218.5818.7715.49126764217.38886538CS
44.135529.123239436614.219.811.84179113815.63986213CS
125.355541.259630200312.9819.89.92210615413.07460741CS
26-15.3945-45.640379484133.7335.5759.92188213716.38070544CS
52-13.2545-41.95789806931.5935.5759.92158437720.70609217CS
156-66.9845-78.509728082585.3289.119.92116117633.21541901CS
260-104.3545-85.05542424122.69180.069.9294065151.8854701CS

QDEL - Frequently Asked Questions (FAQ)

What is the current QuidelOrtho Corporation share price?
The current share price of QuidelOrtho Corporation is US$ 18,3355
How many QuidelOrtho Corporation shares are in issue?
QuidelOrtho Corporation has 68.190.989 shares in issue
What is the market cap of QuidelOrtho Corporation?
The market capitalisation of QuidelOrtho Corporation is USD 1,25B
What is the 1 year trading range for QuidelOrtho Corporation share price?
QuidelOrtho Corporation has traded in the range of US$ 9,92 to US$ 35,575 during the past year
What is the PE ratio of QuidelOrtho Corporation?
The price to earnings ratio of QuidelOrtho Corporation is -0,97
What is the cash to sales ratio of QuidelOrtho Corporation?
The cash to sales ratio of QuidelOrtho Corporation is 0,44
What is the registered address of QuidelOrtho Corporation?
The registered address for QuidelOrtho Corporation is 9975 Summers Ridge Road, San Diego, California, 92121
What is the QuidelOrtho Corporation website address?
The website address for QuidelOrtho Corporation is www.quidelortho.com
Which industry sector does QuidelOrtho Corporation operate in?
QuidelOrtho Corporation operates in the Health Care Equipment & Supplies sector

QDEL Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen